Primary Recipient

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

Amount

$12,424,539.00

Award Date

9/30/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Grant name: POINT. The purpose of the Platelet-Oriented Inhibition in New TIA and minor ischemic stroke (POINT) Trial is to determine the safety and effectiveness of the combination of low-dose aspirin and a medication called clopidogrel (also known by th

Recipients Connected to Award

Recipient	Role	Amount
REGENTS OF THE UNIVERSITY OF MICHIGAN	Sub-recipient	$4,138,078.00
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO	Primary recipient	$2,696,666.00
EMMES CORPORATION, THE	Sub-recipient	$2,553,998.00
EMMES CORPORATION, THE	Sub-recipient	$2,312,816.00
MEDICAL UNIVERSITY OF SOUTH CAROLINA	Sub-recipient	$671,026.00
RHODE ISLAND HOSPITAL	Sub-recipient	$51,955.00